Vivos Therapeutics, Inc. (VVOS) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-15

Vivos Therapeutics, Inc. (VVOS) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-15. 6 Form 8-K material event filings were reported by VVOS in the last 90 days. InsiderAlpha tracks every VVOS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Vivos Therapeutics, Inc. (VVOS)

SEC CIK	0001716166

90-Day SEC Filing Activity

Form 4 filings (90d)	1
Form 8-K filings (90d)	6
Latest Form 4 filing	2026-07-15

Recent VVOS Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-03-31	Skaff Michael C	Insider	P — Open-market purchase	1.04M	$1.34	$1.40M	SEC
2026-03-31	Skaff Michael C	Insider	P — Open-market purchase	308.8K	$1.34	$414K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Vivos Therapeutics, Inc. (VVOS). Updated in real time as new filings are submitted to the SEC.

Most-Active VVOS Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Skaff Michael C	3	$3.20M

Recent VVOS Form 8-K Material Events

2026-07-07 — Item 1.01, 3.02, 5.03, 9.01 [SEC]
2026-06-25 — Item 1.01, 7.01, 9.01 [SEC]
2026-06-16 — Item 8.01, 9.01 [SEC]
2026-06-15 — Item 1.01, 7.01, 9.01 [SEC]
2026-06-08 — Item 1.01, 2.03, 3.01, 3.02, 7.01, 9.01 [SEC]

Recent Insider Filings

2026-07-15 — Skaff Michael C (Insider)
2026-04-02 — Skaff Michael C (Insider)
2024-11-27 — Amman Bradford K. (Chief Financial Officer)
2024-11-27 — Huntsman Ronald Kirk (Chief Executive Officer)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in VVOS insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

VVOS Insider Trading — FAQ

What is the latest insider trade for VVOS?: Vivos Therapeutics, Inc. (VVOS) had 1 insider filings in the last 90 days, with the most recent on 2026-07-15. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying VVOS stock?: 0 insider purchases of VVOS were filed in the last 90 days.
How many insiders are selling VVOS stock?: 0 insider sales of VVOS were filed in the last 90 days.
Where can I see VVOS SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every VVOS SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live VVOS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.